Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study

URN to cite this document:: urn:nbn:de:bvb:355-epub-535783
DOI to cite this document:: 10.5283/epub.53578

Spoerl, Steffen ; Gerken, Michael ; Schimnitz, Susanne ; Taxis, Juergen

; Fischer, René ; Lindner, Sophia R. ; Ettl, Tobias ; Ludwig, Nils

; Spoerl, Silvia ; Reichert, Torsten E. ; Spanier, Gerrit

License: Creative Commons Attribution 4.0
PDF - Published Version
(558kB)

Date of publication of this fulltext: 19 Jan 2023 15:59

Alternative links to fulltext:DOI Publisher

Details

Preview

Indexed in

Export bibliographical data

Abstract

Background: Type 2 Diabetes (DM2) and the consecutively daily use of antidiabetic medication are characterized by a frequent prevalence worldwide and were shown to impact the initiation and progression of malignant diseases. While these effects were observed in a variety of malignancies, comprehensive data about the role of DM2 and antidiabetic drugs in the outcome of head and neck melanoma (HNM) ...